Minocycline Treatment Report
See More Treatments
See all treatments in the PatientsLikeMe system shared by patients just like you.
What is Minocycline?
Minocycline is a second-generation, long-acting tetracycline. It is indicated in the treatment of a variety of bacterial infections, including brain and meningeal infections; it is ten times better able to enter the brain than other tetracycline antibiotics. A European trial in ALS starts in 2007.
Read more...
See more information, including instructions, precautions, side effects, and interactions.
Reasons Taken
101 patients in the community are taking or have taken Minocycline.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Slow my ALS progress | 54 | 53% |
| Other | 20 | 19% |
| Slow my MS progress | 15 | 14% |
| General health | 3 | 2% |
| disease-related symptoms | 2 | 1% |
| Arthritis | 1 | <1% |
| Fatigue | 1 | <1% |
| Acne | 1 | <1% |
Dosages
Based on the patients currently taking Minocycline.
Duration
How long current patients have been taking Minocycline or how long patients were taking Minocycline before stopping.
Currently taking Minocycline
Stopped taking Minocycline
Patient Reported Evaluations
Results from 2 patient evaluations. See the overall results and all individual evaluations.
Efficacy (Effect based on reason taken)
| Can't tell | 100% | 1 |
|---|
Other
Side-effects (as an overall problem)
| Severe | 0% | 0 |
|---|---|---|
| Moderate | 0% | 0 |
| Mild | 0% | 0 |
| None | 100% | 2 |
Summary results are based on 2 individual responses. For more information, see overall results for Adherence, Burden and Cost.
Individual Patient Reported Evaluations (1 of 2)
-
- HopeLives
- Sensation: Moderate
- Overall: Mild
- Cognition: moderate
- Vision: moderate
- Speech: none
- Swallowing: moderate
- Upper limb: moderate
- Walking: moderate
- See profile
-
by HopeLives
Aug 20, 2008
- EfficacyCan't tell
- Side-effectsNone
- Other
- See full evaluation
-
0 helpful marks